Treatment of mCRPC patient with 2 cycles of 67Cu-SAR-bisPSMA (8GBq) leads to undetectable PSA level

Copper-67 production

SAR-bisPSMA – a next-generation radiopharmaceutical for prostate cancer diagnosis and treatment

ShareCafe’s “Hidden Gems” Webinar